SOHO Italy 1st School of Multiple Myeloma

Videos
Event

Daratumumab in MM Daily Practice: Is It Becoming the New Backbone?

By SOHO Italy 1st School of Multiple Myeloma FEATURING Claudio Cerchione

97 views

February 4, 2021

Comments 0

Present Landscape of R/R MM: Post-Bortezomib, Post-Lenalidomide

SOHO Italy 1st School of Multiple Myeloma

C. Cerchione

208 views

Near-Future Therapy Landscape of R/R MM at Second or Subsequent Rela…

SOHO Italy 1st School of Multiple Myeloma

C. Cerchione

139 views

MM & Extracellular Vesicles: Do MICA+ EVs Impair NKG2D-Mediated NK C…

SOHO Italy 1st School of Multiple Myeloma

E. Vulpis

26 views

Cell-Adhesion System Targeting in MM: How Does JAM-A Expression Corr…

SOHO Italy 1st School of Multiple Myeloma

A. Solimando

13 views

Single-Cell Characterization of the BM Immune Microenvironment in MM…

SOHO Italy 1st School of Multiple Myeloma

C. Botta

37 views

ASCT in MM in Novel Agents Era: Is Long-Term Disease Control and Sur…

SOHO Italy 1st School of Multiple Myeloma

A. Olivieri

19 views

Primary Plasma Cell Leukemia Peru Experience: How Common Is PCL in M…

SOHO Italy 1st School of Multiple Myeloma

J. Vasquez

37 views

1st/2nd Relapse in MM: Predictive Factors, EMD, Role of sFLC in MGUS…

SOHO Italy 1st School of Multiple Myeloma

U. Markovic

21 views

Extracellular Vesicles in Myeloma: What Is Their Role in MGUS-to-MM …

SOHO Italy 1st School of Multiple Myeloma

A. Reale

23 views

MRD Assessment Within the Bone Marrow of MM: Immunoglobulin Genes as…

SOHO Italy 1st School of Multiple Myeloma

C. Terragna

82 views

Molecular Pathogenesis of MM: MGUS and SMM, Genomic Complexity of th…

SOHO Italy 1st School of Multiple Myeloma

N. Bolli

205 views

Bone Marrow Fibroblasts in MM Progression and Tumor Cells Reprogramm…

SOHO Italy 1st School of Multiple Myeloma

I. Saltarella

The Myeloma-Specific Tumor Suppressor FAM46C: How Does It Work & Wha…

SOHO Italy 1st School of Multiple Myeloma

E. Milan

9 views

1L LenDex Combo in Frail MM Patients: How Effective Is It? Is There …

SOHO Italy 1st School of Multiple Myeloma

C. Bellofiore

10 views

NGS in ALL: Is INO Effective in MRD+ Patients Before HSCT? How Valua…

SOHO Italy 1st School of Multiple Myeloma

G. Martinelli

178 views

Anti-CD38 in MM Daily Practice: How Can We Potentiate the Action of …

SOHO Italy 1st School of Multiple Myeloma

C. Cerchione

95 views

Introducing Anti-CD38 in Daily Practice of MM: Updates on the GRIFFI…

SOHO Italy 1st School of Multiple Myeloma

C. Cerchione

98 views

Daratumumab in MM Daily Practice: Is It Becoming the New Backbone?

SOHO Italy 1st School of Multiple Myeloma

C. Cerchione

97 views

Bone Marrow CD8+ Tissue-Resident Memory T-Cells in MM: Can the Incre…

SOHO Italy 1st School of Multiple Myeloma

M. Carlisi

10 views

European Experience in MM: What Are the Potential 1L Options for Tra…

SOHO Italy 1st School of Multiple Myeloma

M. Mateos

20 views

Exploring Microenvironment of Multiple Myeloma: How Important Is It …

SOHO Italy 1st School of Multiple Myeloma

A. Romano

19 views

2021 Update Combination Therapies in R/R MM: Which Options Are the M…

SOHO Italy 1st School of Multiple Myeloma

F. Fazio

15 views

Dissecting Daratumumab Mechanisms of Resistance in MM: Identificatio…

SOHO Italy 1st School of Multiple Myeloma

M. Claudio Da Via

129 views

Comparison of Different Imaging Techniques in MM: Whole-Body Compute…

SOHO Italy 1st School of Multiple Myeloma

S. Grammatico

17 views

Combination Therapy in MM: Does Doxorubicin & ENPP1 Inhibitor Combin…

SOHO Italy 1st School of Multiple Myeloma

L. Cuollo

27 views

Allograft in MM: Is There a Role for AlloHSCT & Will Newer Drug Ther…

SOHO Italy 1st School of Multiple Myeloma

F. Vozella

2021 Update on R/R MM: Does the Addition of BCNU to Melphalan Improv…

SOHO Italy 1st School of Multiple Myeloma

J. Thomas

26 views

Login

Login

Join VuMedi